Clinical Trials Browser

Phase 2 × Completed × idecabtagene vicleucel × Clear all

NCT05032820 2026-05-19

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

Phase 2 Completed

40 enrolled 32 charts

Hematologic Diseases, Multiple Myeloma

NCT03601078 2026-03-04

KarMMa-2

Phase 2 Completed

Multiple Myeloma, Recurrence

NCT03361748 2025-05-23

KarMMa

Phase 2 Completed

149 enrolled 29 charts

Multiple Myeloma, Recurrence